G. Shevchenko

发表

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease

K. Kultima, P. Nilsson, J. Bergquist, 2016, PloS one.

Neuroproteomics tools in clinical practice.

Jonas Bergquist, Anne Konzer, J. Bergquist, 2015, Biochimica et biophysica acta.

Proteomic differences between focal and diffuse traumatic brain injury in human brain tissue

J. Bergquist, N. Marklund, Jia Mi, 2018, Scientific Reports.

Longitudinal characterization of the brain proteomes for the tg2576 amyloid mouse model using shotgun based mass spectrometry.

K. Kultima, J. Bergquist, K. Höglund, 2012, Journal of proteome research.

Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.

K. Kultima, P. Nilsson, J. Bergquist, 2016, Journal of Alzheimer's disease : JAD.

Increased CSF levels of apolipoproteins and complement factors in trigeminal neuralgia patients - in depth proteomic analysis using mass spectrometry.

K. Kultima, T. Gordh, P. E. Khoonsari, 2020, The journal of pain : official journal of the American Pain Society.

Muscle RING-finger protein-1 (MuRF1) functions and cellular localization are regulated by SUMO1 post-translational modification

S. Gastaldello, Geng Tian, G. Shevchenko, 2018, Journal of molecular cell biology.

Electrical stimulated GLUT4 signalling attenuates critical illness-associated muscle wasting.

L. Larsson, A. Addinsall, G. Shevchenko, 2022, Journal of cachexia, sarcopenia and muscle.

Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis

B. Winblad, P. Visser, B. Tijms, 2022, Acta neuropathologica communications.

A simplified and sensitive immunoprecipitation mass spectrometry protocol for the analysis of amyloid-beta peptides in brain tissue.

T. Bayer, J. Bergquist, G. Shevchenko, 2019, Clinical Mass Spectrometry.

Decorin is an early CSF biomarker of Alzheimer’s Aβ amyloidosis

B. Winblad, P. Visser, J. Bergquist, 2021, Alzheimer's & Dementia.

Analysis of membrane and hydrophilic proteins simultaneously derived from the mouse brain using cloud-point extraction

J. Bergquist, M. Sjödin, G. Shevchenko, 2011, Analytical and bioanalytical chemistry.

Single-Shot Vaccines against Bovine Respiratory Syncytial Virus (BRSV): Comparative Evaluation of Long-Term Protection after Immunization in the Presence of BRSV-Specific Maternal Antibodies

L. Jouneau, Baoshan Zhang, P. Kwong, 2021, Vaccines.

Electrical stimulated GLUT4 signalling attenuates critical illness‐associated muscle wasting

L. Larsson, A. Addinsall, G. Shevchenko, 2021, bioRxiv.

Role of Extracellular Vesicles in Pulmonary Arterial Hypertension

A. Siegbahn, G. Wikström, G. Shevchenko, 2020, Arteriosclerosis, thrombosis, and vascular biology.

Comparison of extraction methods for the comprehensive analysis of mouse brain proteome using shotgun-based mass spectrometry.

J. Bergquist, G. Shevchenko, Sravani Musunuri, 2012, Journal of proteome research.

Cloud-point extraction and delipidation of porcine brain proteins in combination with bottom-up mass spectrometry approaches for proteome analysis.

J. Bergquist, M. Sjödin, G. Shevchenko, 2010, Journal of proteome research.

Identification of Injury Specific Proteins in a Cell Culture Model of Traumatic Brain Injury

L. Hillered, G. Shevchenko, F. Clausen, 2013, PloS one.

Increased Release of Apolipoprotein E in Extracellular Vesicles Following Amyloid-β Protofibril Exposure of Neuroglial Co-Cultures

K. Kultima, M. Ingelsson, P. E. Khoonsari, 2017, Journal of Alzheimer's disease : JAD.

The polyamine transporter Slc18b1(VPAT) is important for both short and long time memory and for regulation of polyamine content in the brain

K. Kullander, J. Bergquist, H. Schiöth, 2019, PLoS genetics.

Micellar extraction possesses a new advantage for the analysis of Alzheimer’s disease brain proteome

K. Kultima, J. Bergquist, L. Lannfelt, 2015, Analytical and Bioanalytical Chemistry.

Quantification of the brain proteome in Alzheimer's disease using multiplexed mass spectrometry.

K. Kultima, J. Bergquist, L. Lannfelt, 2014, Journal of proteome research.

Neuroproteomic profiling of human brain tissue using multidimensional separation techniques and selective enrichment of membrane proteins

J. Bergquist, G. Shevchenko, Sravani Musunuri, 2012, Electrophoresis.

Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer

P. Malmström, U. Segersten, A. Valdés, 2021, Scientific Reports.

A Single Shot Pre-fusion-Stabilized Bovine RSV F Vaccine is Safe and Effective in Newborn Calves with Maternally Derived Antibodies

L. Jouneau, Baoshan Zhang, P. Kwong, 2020, Vaccines.

Plasma-derived extracellular vesicles from myocardial infarction patients inhibits tumor necrosis factor-alpha induced cardiac cell death.

A. Siegbahn, B. Lindahl, G. Shevchenko, 2021, Current research in translational medicine.

Alterations in muscle proteome of patients diagnosed with amyotrophic lateral sclerosis.

J. Bergquist, L. Larsson, H. Askmark, 2014, Journal of proteomics.

A Feasibility Study on the Identification of Potential Biomarkers in Pulmonary Embolism Using Proteomic Analysis

D. Bylund, G. Shevchenko, S. Lind, 2022, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Identification of cytoskeletal proteins as binding partners of Bri2 BRICHOS domain

R. Moaddel, G. Shevchenko, P. Nilsson, 2023, Molecular and Cellular Neuroscience.

Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease

P. Svenningsson, J. Bergquist, D. Nyholm, 2020, Movement disorders : official journal of the Movement Disorder Society.

Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers

Stephanie Herman, K. Kultima, P. Nilsson, 2019, Journal of Alzheimer's disease : JAD.

Chitinase-3-like protein 1 (CH3L1) and Neurosecretory protein VGF (VGF) as two novel CSF biomarker candidates for improved diagnostics in Alzheimer’s disease

Stephanie Herman, K. Kultima, P. Nilsson, 2017 .